NCT04855760Phase 3Completed

Safety of REL-1017 for Major Depressive Disorder

Study sponsor: Relmada Therapeutics, Inc. · RLMD

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2023-07-27Actual

Enrollment · participants627Actual

Source updated2025-02-11Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.